<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1532</number>
    <updateDate>2025-09-30T22:58:40Z</updateDate>
    <updateDateIncludingText>2025-09-30T22:58:40Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2025-02-24</introducedDate>
    <congress>119</congress>
    <legislationUrl>https://www.congress.gov/bill/119th-congress/house-bill/1532</legislationUrl>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 171, Number 36 (Monday, February 24, 2025)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. MATSUI:H.R. 1532.Congress has the power to enact this legislation pursuantto the following:section 8 of article I of the Constitution[Page H769]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2025-02-24T17:04:05Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Scientific EXPERT Act of 2025</title>
        <congress>119</congress>
        <number>822</number>
        <type>S</type>
        <latestAction>
          <actionDate>2025-03-03</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2025-02-24</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2025-02-24</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-02-24</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>M001163</bioguideId>
        <fullName>Rep. Matsui, Doris O. [D-CA-7]</fullName>
        <firstName>Doris</firstName>
        <lastName>Matsui</lastName>
        <party>D</party>
        <state>CA</state>
        <middleName>O.</middleName>
        <district>7</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B001257</bioguideId>
        <fullName>Rep. Bilirakis, Gus M. [R-FL-12]</fullName>
        <firstName>Gus</firstName>
        <lastName>Bilirakis</lastName>
        <party>R</party>
        <state>FL</state>
        <middleName>M.</middleName>
        <district>12</district>
        <sponsorshipDate>2025-02-24</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>T000469</bioguideId>
        <fullName>Rep. Tonko, Paul [D-NY-20]</fullName>
        <firstName>Paul</firstName>
        <lastName>Tonko</lastName>
        <party>D</party>
        <state>NY</state>
        <district>20</district>
        <sponsorshipDate>2025-06-10</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Advisory bodies</name>
          <updateDate>2025-07-17T19:23:14Z</updateDate>
        </item>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2025-07-17T19:23:40Z</updateDate>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
          <updateDate>2025-07-17T19:23:02Z</updateDate>
        </item>
        <item>
          <name>Government information and archives</name>
          <updateDate>2025-07-17T19:23:19Z</updateDate>
        </item>
        <item>
          <name>Medical research</name>
          <updateDate>2025-07-17T19:22:56Z</updateDate>
        </item>
        <item>
          <name>Research administration and funding</name>
          <updateDate>2025-07-17T19:23:07Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2025-03-17T15:58:01Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2025-02-24</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2025-08-12T21:02:25Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Scientific External Process for Educated Review of Therapeutics Act of 2025 or the Scientific EXPERT Act of 2025&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill requires the Food and Drug Administration (FDA) to facilitate and participate in externally led, science-focused drug development meetings to discuss the development of treatments for rare diseases and conditions.&amp;nbsp;&lt;/p&gt;&lt;p&gt;The FDA must enter into an arrangement with the Reagan-Udall Foundation for the FDA under which the foundation agrees to convene such meetings. Meetings must be held at least four times a year, and each meeting must focus on a different rare disease or condition.&amp;nbsp;&lt;/p&gt;&lt;p&gt;The foundation must establish a permanent steering committee to review and recommend topics for each meeting. In evaluating potential topics, the committee must consider unmet therapeutic needs, patient population sizes for different diseases and conditions, and whether a disease or condition would benefit from clarity and alignment on drug development questions, among other factors.&amp;nbsp;&lt;/p&gt;&lt;p&gt;In planning each meeting, the foundation must develop a list of medical experts, drug sponsors, scientific organizations, patient organizations, and other entities to be invited to participate. Representatives of the FDAâ€™s review divisions must attend each meeting.&amp;nbsp;&lt;/p&gt;&lt;p&gt;After each meeting, the foundation must make available a summary of the meeting noting areas of consensus, areas where additional clarification or information is needed, and next steps agreed upon with the FDA.&lt;/p&gt;&lt;p&gt;The bill also requires the FDA to indicate whether it incorporated any input from these meetings when approving a new drug or biologic.&amp;nbsp;&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Scientific EXPERT Act of 2025</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Scientific EXPERT Act of 2025</title>
        <updateDate>2025-03-14T09:38:22Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Scientific EXPERT Act of 2025</title>
        <updateDate>2025-03-14T09:38:19Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Scientific External Process for Educated Review of Therapeutics Act of 2025</title>
        <updateDate>2025-03-14T09:38:19Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.</title>
        <updateDate>2025-03-14T09:33:25Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2025-02-24T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119hr1532ih/xml/BILLS-119hr1532ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2025-02-24</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
